CDEK
← All organizations

Organon

For profitContributed to NME

Also known as: Merck Teknika LLC | Organon | ORGANON | Organon and Co | Organon GmbH (former name) | Organon Healthcare GmbH | ORGANON LLC | ORGANON SUB MERCK | Organon Teknika | ORGANON USA INC | Organon USA Inc., a subsidiary of Merck & Co., Inc. | Organon USA LLC, a subsidiary of Organon & Co. | ORGANON USA ORGANON | Zwanenberg Organon

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Jan 1, 2000

First marketed drug

Feb 9, 1939

First NDA

Feb 9, 1939

Last known activity

Dec 31, 2025

Acquired by Schering-Plough → Merck on Nov 1, 2007

Timeline

1920s

  1. Jan 1, 1923

    Organon— Founded

1990s

  1. Apr 14, 1995

    losartan— NDA Secondary Org

  2. Jun 14, 1996

    mirtazapine— NDA Organization

  3. Feb 20, 1998

    montelukast— Marketing Organization

2000s

  1. Jan 1, 2007

    Nobilon International BV— Acquired

  2. Nov 1, 2007

    Schering-Plough— Acquired By

  3. Jan 1, 2009

    Merck— Now

2020s

  1. Nov 13, 2021

    Forendo Pharma Ltd— Acquired

Drugs by trial phase (36 distinct, 27 trials)

Other trials (2 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (51)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (27)

Details

Founded
Oss, NL Jan 1, 1923
First NDA
Feb 9, 1939
Last known activity
Dec 31, 2025

Designations held

  • Priority review